Expert Insights for Health Science Companies

As a global leader in health science M&A, recapitalization, and growth financing strategies, Crosstree has led 100+ transactions for companies at the center of this fast-moving industry.

Video

Future of Clinical Trials

July 16, 2020

Until now innovation in Pharma Services has been evolutionary. As we come back from COVID, the industry will need to…

Watch Video
BlueBook

Diagnostics & Tools December 2020

Philips has agreed to acquire BioTelemetry for $2.8bb Verily Life Sciences received a $700mm round of funding Everly Well received...

BlueBook

Pharma Services December 2020

Trifecta was acquired by WCG Honeywell has agreed to acquire Sparta Systems for $1.3bb Tempus Labs received a $450mm round...

Deal Insights

Uniting Trifecta’s Remote Study Startup and Compliance Support With WCG’s Suite of “Smart Trial” Solutions

December 4, 2020

BlueBook

Pharma Services November 2020

IntegReview IRB was acquired by Advarra Shanghai Youlin Pharmaceutical Technology closed a $14.9mm round of funding, led by Cenova Ventures...

View All

We were impressed with the intensity and thoroughness of Crosstree’s preparation. Their team worked tirelessly on analytics and positioning, ultimately giving us the flexibility to efficiently navigate various strategic options involving our business and each of its two divisions. I wouldn’t think twice about using Crosstree again.

Crosstree did an exceptional job with our process. We benefited greatly from their industry knowledge, expansive network, deal expertise and just plain hard work. Most importantly, their bankers demonstrated sterling integrity and always gave us sound advice that resulted in an excellent outcome, despite numerous twists and turns along the way.

Crosstree’s specific knowledge of our market segment allowed them to precisely target potential buyers. Further, Crosstree guided management to the right “value drivers” for each potential buyer, optimally tuning our various presentations, and ultimately driving enhanced valuations during the auction process.

Explore greater market insights and financial possibilities with the leading experts in health science.

Jeff Ellis

Jeff Ellis

Co-Founder & Managing Director
Shane Senior, CFA

Shane Senior, CFA

Co-Founder & Managing Director
Frederic Laurier

Frederic Laurier

Managing Director
Zeke Navar

Zeke Navar

Managing Director
Rusty Ray

Rusty Ray

Managing Director
Gordon Ryerson

Gordon Ryerson

Managing Director
Lance Converse

Lance Converse

Managing Partner - Crosstree Equity Fund
Roman Margolin

Roman Margolin

Managing Partner - Crosstree Equity Fund
Christian Carlson, PhD

Christian Carlson, PhD

Director
Jason Layton

Jason Layton

Director
Andrew Barry

Andrew Barry

Associate
Stefanie Hilton

Stefanie Hilton

Associate
Frank Perilli

Frank Perilli

Associate
Jay Sojdehei

Jay Sojdehei

Associate
Camden Anderson

Camden Anderson

Analyst
Nic Gianelli

Nic Gianelli

Analyst
Ryan Silvester

Ryan Silvester

Analyst
Jamie Keithahn

Jamie Keithahn

Associate
Michael Levin

Michael Levin

Associate
Zach Zientarski

Zach Zientarski

Analyst
Patti-Ann Dresback

Patti-Ann Dresback

Vice President of Operations
Kyle Hill

Kyle Hill

Research Associate
Ray Lens

Ray Lens

Research Analyst
Meet Our Experts